InMode (INMD) Cash from Investing Activities (2018 - 2026)

InMode's (INMD) quarterly Cash from Investing Activities came in at $109.1 million in Q1 2026, up 44.54% year-on-year from $75.5 million in Q1 2025, and up 300.78% quarter-over-quarter from $27.2 million in Q4 2025.

InMode (INMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends

InMode has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $109.1 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $109.1 million, up 44.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $219.6 million (down 22.95% YoY), and the FY2025 annual result was $186.0 million, up 14.69% from the prior year.
  • Cash from Investing Activities came in at $109.1 million for Q1 2026 at InMode, up from $27.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $114.1 million in Q3 2024 to a low of -$69.8 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $11.7 million (2025), against an average of $12.5 million.
  • Peak annual rise in Cash from Investing Activities reached 647.89% in 2023, while the deepest fall reached 117.11% in 2023.
  • InMode's Cash from Investing Activities stood at -$38.3 million in 2022, then tumbled by 34.79% to -$51.6 million in 2023, then surged by 250.84% to $77.8 million in 2024, then plunged by 65.02% to $27.2 million in 2025, then surged by 300.78% to $109.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at $109.1 million (Q1 2026), $27.2 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 InMode 3.35 -388.37 Mn 61.55 Mn 109.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.10 Mn
Mar 31, 2026 109.10 Mn
Dec 31, 2025 27.22 Mn
Dec 31, 2025 27.22 Mn
Sep 30, 2025 11.67 Mn
Sep 30, 2025 11.67 Mn
Jun 30, 2025 71.66 Mn
Jun 30, 2025 71.66 Mn
Mar 31, 2025 75.49 Mn
Mar 31, 2025 75.49 Mn
Dec 31, 2024 77.82 Mn
Dec 31, 2024 77.82 Mn
Sep 30, 2024 114.06 Mn
Sep 30, 2024 114.06 Mn
Jun 30, 2024 17.73 Mn
Jun 30, 2024 17.73 Mn
Mar 31, 2024 -47.39 Mn
Mar 31, 2024 -47.39 Mn
Dec 31, 2023 -51.59 Mn
Dec 31, 2023 -51.59 Mn